Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10352648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus.

  1997cited by this paper
• Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.

  1997cited by this paper
• Malignancy in systemic lupus erythematosus.

  1996cited by this paper
• Prognosis and treatment of systemic lupus erythematosus.

  1996cited by this paper
• Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes.

  1995cited by this paper
• Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.

  1995cited by this paper
• Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort.

  1995cited by this paper
• Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

  1995cited by this paper
• Systemic Lupus Erythematosus: Emerging Concepts: Part 2: Dermatologic and Joint Disease, the Antiphospholipid Antibody Syndrome, Pregnancy and Hormonal Therapy, Morbidity and Mortality, and Pathogenesis

  1995cited by this paper
• Predicting outcome in current clinic attenders: a biased view.

  1994cited by this paper
• Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables.

  1994cited by this paper
• Survival of Chilean patients with systemic lupus erythematosus.

  1994cited by this paper
• Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.

  1994cited by this paper
• The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990.

  1993cited by this paper
• Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

  1993cited by this paper
• Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients.

  1993cited by this paper
• Systemic Lupus Erythematosus in Greece. Clinical Features, Evolution and Outcome: a Descriptive Analysis of 292 Patients

  1993cited by this paper
• Morbidity of systemic lupus erythematosus: role of race and socioeconomic status

  1992cited by this paper
• Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

  1992cited by this paper
• Mortality in systemic lupus erythematosus: active disease is the most important factor.

  1992cited by this paper
• Increased risk of cancer in patients with systemic lupus erythematosus.

  1992cited by this paper
• Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determinations.

  1991cited by this paper
• Guidelines for Testing and Revised Criteria for Lupus Anticoagulants

  1991cited by this paper
• Variables associated with decreased survival in systemic lupus erythematosus.

  1991cited by this paper
• Lupus erythematosus in the 1980s: a survey of 570 patients.

  1991cited by this paper
• Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population.

  1990cited by this paper
• Survival pattern of 120 males with systemic lupus erythematosus.

  1990cited by this paper
• Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death.

  1990cited by this paper
• Mortality of Jamaican patients with systemic lupus erythematosus.

  1989cited by this paper
• Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively.

  1989cited by this paper
• Outcome in Systemic Lupus Erythematosus: A Prospective Study of Patients from a Defined Population

  1989cited by this paper
• Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

  1987cited by this paper
• Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors.

  1987cited by this paper
• Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria.

  1985cited by this paper
• Mortality in systemic lupus erythematosus: the bimodal pattern revisited.

  1985cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.

  1982cited by this paper
• Systemic lupus erythematosus--survival patterns. Experience with 609 patients.

  1981cited by this paper
• Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis.

  1976cited by this paper
• The bimodal mortality pattern of systemic lupus erythematosus.

  1976cited by this paper
• Estimating prognosis in systemic lupus erythematosus.

  1974cited by this paper
• THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS

  1971cited by this paper
• SYSTEMIC LUPUS ERYTHEMATOSUS. A STATISTICAL EVALUATION OF MORTALITY BASED ON A CONSECUTIVE SERIES OF 299 PATIENTS.

  1964cited by this paper
• Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.

  1955cited by this paper

• Comprehensive Analysis of Thrombocytopenia in Systemic Lupus Erythematosus: Prevalence, Immunological Correlations, and Mortality Outcomes in the Oman Lupus Cohort

  2025cites this paper
• A Case Report and Literature Review of ANCA-Associated Vasculitis and Lupus Nephritis Overlap: Lessons in Management

  2025cites this paper
• SLE classification criteria item relationships: implications on SLE as a disease entity.

  2025cites this paper
• The role of peritubular capillaritis in severity of lupus nephritis

  2025cites this paper
• Acute Lupus Pneumonitis and Severe Multisystem Complications: A Complex Inpatient Course

  2025cites this paper
• Unveiling pleuropulmonary manifestations in systemic lupus erythematosus: a retrospective observational study from the Middle East

  2025cites this paper
• Lupus nephritis: management challenges during pregnancy

  2024cites this paper
• Opportunities and challenges of lupus care in Latin America, the Middle East, and Asia-Pacific: A call to action.

  2024cites this paper
• Risk assessment tool for anemia of chronic disease in systemic lupus erythematosus: a prediction model

  2024cites this paper
• Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.

  2024cites this paper
• Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data

  2024cites this paper
• Ten tips in lupus nephritis management

  2024cites this paper
• Severe thrombocytopenia is associated with high mortality in systemic lupus erythematosus—analysis from Indian SLE Inception cohort for Research (INSPIRE)

  2023cites this paper
• Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review

  2022cites this paper
• Severe Thrombocytopenia as the Main Manifestation of Childhood-Onset Systemic Lupus Erythematosus

  2022cites this paper
• Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network

  2022cites this paper
• Advances in SLE classification criteria.

  2022cites this paper
• Low-dose IL-2 therapy limits the reduction in absolute numbers of peripheral lymphocytes in systemic lupus erythematosus patients with infection

  2022cites this paper
• Effects of Systemic Lupus Erythematosus on Clinical Outcomes and In-Patient Mortality Among Hospitalized Patients With Diverticulitis

  2022cites this paper
• The neurology of lupus.

  2021cites this paper
• Cardiovascular Disease in Systemic Lupus Erythematosus

  2021cites this paper
• Rapid and precise diagnosis of pneumonia coinfected by Pneumocystis jirovecii and Aspergillus fumigatus assisted by next-generation sequencing in a patient with systemic lupus erythematosus: a case report

  2021cites this paper
• Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

  2021cites this paper
• Recurrent lupus nephritis in renal allograft triggered by pregnancy

  2021cites this paper
• Bacterial infections in lupus: Roles in promoting immune activation and in pathogenesis of the disease

  2020cites this paper
• Associations Between Classification Criteria Items in Systemic Lupus Erythematosus

  2020cites this paper
• Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review

  2020cites this paper
• Systemic lupus erythematosus in the intensive care unit: a systematic review

  2020cites this paper
• Prevalence and incidence of systemic lupus erythematosus in Tucumán, Argentina

  2020cites this paper
• FcγRIIA expression aggravates nephritis and increases platelet activation in systemic lupus erythematosus in mice.

  2020cites this paper
• The Cardio-Rheumatology Approach to Atherosclerotic Cardiovascular Disease.

  2020cites this paper
• Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases.

  2020cites this paper
• Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

  2019cites this paper
• Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival

  2019cites this paper
• Acute ST-elevation myocardial infarction in a young patient with antiphospholipid syndrome

  2019cites this paper
• Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus

  2019cites this paper
• Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus

  2019cites this paper
• Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus

  2019cites this paper
• EULAR/ACR classification criteria for SLE.

  2019cites this paper
• The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts

  2019cites this paper
• Pseudo-pseudo Meigs’ syndrome presenting with a combination of polyserositis, elevated serum CA 125 in systemic lupus erythematosus

  2019cites this paper
• Burden of comorbidities in South Africans with systemic lupus erythematosus

  2019cites this paper
• Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes

  2019cites this paper
• Treatment of primary and secondary immune thrombocytopenia

  2019cites this paper
• A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus

  2019cites this paper
• Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort

  2019cites this paper
• Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes

  2019cites this paper
• Growing international evidence for urinary biomarker panels identifying lupus nephritis in children – verification within the South African Paediatric Lupus Cohort

  2018cites this paper
• Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.

  2018cites this paper
• Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration

  2018cites this paper
• Entheseal involvement in patients with systemic lupus erythematosus: an ultrasound study

  2018cites this paper
• The non-haemostatic role of platelets in systemic lupus erythematosus

  2018cites this paper
• Pneumonia in patients with systemic lupus erythematosus: Epidemiology, microbiology and outcomes

  2018cites this paper
• Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience

  2018cites this paper
• Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus

  2018cites this paper
• Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis

  2018cites this paper
• Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies

  2018cites this paper
• The Montreal Cognitive Assessment Test

  2018cites this paper
• 6 Atherogenesis and Vascular Disease in SLE

  2018cites this paper
• Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases.

  2018cites this paper
• Central Nervous System Manifestations of Systemic Lupus Erythematosus.

  2017cites this paper
• Title Concurrent presentation of cryptococcal meningoencephalitis and systemiclupus erythematosus

  2017cites this paper
• H1N1 vaccination in Sjögren’s syndrome triggers polyclonal B cell activation and promotes autoantibody production

  2017cites this paper
• [Systemic lupus erythematosus and lymphopenia: Clinical and pathophysiological features].

  2017cites this paper
• Epidemiology of systemic lupus erythematosus

  2017cites this paper
• Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

  2017cites this paper
• Thrombocytopenia in Systemic Lupus Erythematosus

  2016cites this paper
• Clinical features and outcome of pregnancy with SLE-associated thrombocytopenia

  2016cites this paper
• Open Peer Review

  2016cites this paper
• Systemic lupus erythematosus

  2016cites this paper
• New insights into the immunopathogenesis of systemic lupus erythematosus

  2016cites this paper
• Clinical characteristics of immune thrombocytopenia associated with autoimmune disease

  2016cites this paper
• Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.

  2016cites this paper
• Clinical features and independent predictors of interstitial lung disease in systemic lupus erythematosus

  2016cites this paper
• A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis

  2016cites this paper
• Granulomatous Diseases Affecting Jaws.

  2016cites this paper
• The diagnosis and management of the haematologic manifestations of lupus.

  2016cites this paper
• Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus

  2016cites this paper
• The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus

  2016cites this paper
• Necrose de medula óssea em paciente portadora de lúpus eritematoso sistêmico

  2016cites this paper
• Toward new criteria for systemic lupus erythematosus—a standpoint

  2016cites this paper
• Prevalence of the American College of Rheumatology hematological classification criteria and associations with serological and clinical variables in 460 systemic lupus erythematosus patients

  2015cites this paper
• Lupus Nephritis: A Different Disease in European Patients?

  2015cites this paper
• Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus.

  2015cites this paper
• Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary.

  2015cites this paper
• Cardiovascular risk in lupus nephritis: Do renal disease-related and other traditional risk factors play a role?

  2015cites this paper
• Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis

  2015cites this paper
• Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype

  2015cites this paper
• Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases.

  2015cites this paper
• Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

  2015cites this paper
• Importancia de las infecciones en el lupus eritematoso sistémico

  2015cites this paper
• Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus

  2015cites this paper
• The Diagnosis and Treatment of Systemic Lupus Erythematosus.

  2015cites this paper
• Cardiorheumatology: cardiac involvement in systemic rheumatic disease

  2015cites this paper
• Lupus erythematosus revisited

  2015cites this paper
• Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies.

  2015cites this paper
• Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.

  2014cites this paper
• [Assessment of endothelial function in autoimmune diseases].

  2014cites this paper
• Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside

  2014cites this paper
• Novosti u liječenju sustavnoga eritemskog lupusa

  2014cites this paper